Article | REF: PHA3051 V1

Quality risk management applied to pharmaceutical product development

Authors: Jean-Jacques HOURI, Mélisande BERNARD, Hassane SADOU-YAYE, Bernard DO

Publication date: February 10, 2016

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


Français

2. First development phase: identification of the product's target quality profile and its critical attributes

The QTPP can be defined on the basis of clinical data, the pharmacokinetic characteristics of the active substance and the commercial objectives to be achieved. The example of QTPP presented in table 2 can of course be re-evaluated at a later stage, in the light of knowledge acquired during the development process.

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Drugs and pharmaceuticals

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
First development phase: identification of the product's target quality profile and its critical attributes
Outline